All articles by Linda Stewart – Page 60
-
NewsFamily of parasite proteins presents new potential malaria treatment target
Researchers from the Francis Crick Institute and the Gulbenkian Institute for Molecular Medicine (GIMM) have shown that the evolution of a family of exported proteins in the malaria-causing parasite Plasmodium falciparum enabled it to infect humans. Source: Ernst Hempelmann Ring stage of Plasmodium falciparum in human red blood ...
-
NewsVicious cycle: How methane emissions from warming wetlands could exacerbate climate change
Warming in the Arctic is intensifying methane emissions, contributing to a vicious feedback loop that could accelerate climate change even more, according to a new study.
-
NewsNew molecular movie reveals how antibiotic resistance to fusidic acid works
Researchers revealed how FusB, a resistance protein found in clinically resistant strains of the bacterium Staphylococcus aureus, can rescue ribosomes from the antibiotic fusidic acid. FusB works like a molecular crowbar to free the blocked ribosome.
-
NewsWastewater treatment to fight the spread of antibiotic resistance
A metagenomics study has demonstrated that one type of bioreactor used in some wastewater plants – anaerobic membrane bioreactors – may be better at reducing the amount of ARGs released into the environment.
-
NewsAmericans say benefits of MMR vaccine for children outweigh risks by nearly 5-1
While many Americans know how measles can spread, most cannot accurately estimate the prevalence of complications associated with measles such as hospitalization or the risks it presents during pregnancy, according to a new survey.
-
NewsAI predicts bacterial resistance to cleaning agents
With the help of artificial intelligence and DNA decoding, a new method can predict how well disease-causing bacteria such as Listeria tolerate disinfectants. This research may become a valuable weapon in the fight against harmful bacteria.
-
NewsResearchers find CRISPR is capable of even more than we thought
Researchers studying key immune components of some CRISPR systems have announced the newest CARF effector they’ve discovered, which they coined Cat1 - it can deplete a metabolite essential for cellular function.
-
NewsNew treatment targets link between viral infection and Alzheimer’s disease
A unique mechanism triggering Alzheimer’s disease draws attention: viral infection—while ALT001 is confirmed to alleviate neuroinflammation and suppress viral replication.
-
NewsParticles carrying multiple vaccine doses could reduce the need for follow-up shots
Researchers are working to develop microparticles that can release their payload weeks or months after being injected. This could lead to vaccines that can be given just once, with several doses that would be released at different time points.
-
NewsThe Global Fund to fight AIDS, Tuberculosis and Malaria ‘should step up efforts’
The international community must protect global responses to HIV, tuberculosis (TB), and malaria to serve humanity’s collective interests, according to a new opinion article.
-
NewsTwo HIV vaccine trials show proof of concept for pathway to broadly neutralizing antibodies
A new study combining data from two separate phase 1 clinical trials shows that a targeted vaccine strategy can successfully activate early immune responses relevant to HIV, and, in one trial, further advance them.
-
NewsResearchers and students transform Milan into outdoor lab for ambitious citizen science urban microbiome study
Researchers and students from the University of Milano-Bicocca - including AMI student member Giulia Ghisleni - teamed up for an ambitious citizen science project, collecting more than 2,400 samples of the urban microbiome over four seasons.
-
NewsProof of concept for HIV vaccination that deploys germline-targeting
For a preventative HIV-vaccine to work it should induce broadly neutralising antibodies against all the diverse strains of the virus. The first in-human assessment of germline-targeting strategy with a trimer displays positive results.
-
NewsScientists find two brain biomarkers in long COVID sufferers may be what’s causing brain fog
A new study that compares inflammation and brain stress responses in long COVID-19 patients with individuals who have fully recovered shows those with cognitive issues have a lower ability to adapt to stress and higher levels of inflammation in their brains.
-
NewsWorld’s largest bat organoid platform paves the way for pandemic preparedness
Researchers have created the world’s most comprehensive bat organoid platform. These ’mini-organs’ are grown from five common bat species found across Asia and Europe and represent four different organs—airway, lungs, kidneys, and small intestine.
-
NewsClimate change is turning coastal lagoons into ‘salty soup’
The impacts of human activity and climate change are coalescing to make coastal lagoons saltier, changing the microbial life they support and the function they play in their ecosystems, according to new research.
-
NewsCombining laboratory techniques yields wealth of information about deadly brain tumors
In a new study, researchers injected into the tumor a virus aimed at killing glioblastoma cells. Surgeons took tumor tissue samples and ran them through multiple advanced laboratory techniques to demonstrate that even small tissue samples can yield additional insights.
-
NewsYellow fever vaccination: how strong immune responses are triggered
Researchers have shown how specific immune cells are activated by the vaccine – an important starting point for the development of new vaccines.
-
NewsScientist awarded $500,000 Gruber Genetics Prize for pioneering discoveries in bacterial immune systems
The 2025 Gruber Genetics Prize is being awarded to geneticist and molecular biologist Rotem Sorek, Ph.D., of the Weizmann Institute of Science, for his discoveries in the immune system of bacteria.
-
NewsNew hope against superbugs: Promising antibiotic candidate discovered
An international team of researchers has discovered saarvienin A, a new type of glycopeptide antibiotic. Their findings introduce a compound with strong activity against highly resistant bacterial strains.